Tag: ROCHE

Appointment Of Ashley Magargee To Chief Executive Officer Genentech

by Editor • December 14, 2023

South San Francisco, CA December 14, 2023 Press Release Ashley Magargee has been appointed to the role of Chief Executive Officer of Genentech, a member of the Roche Group, effective January 1, 2024. In addition to her role as Head…

FDA Approves Zelboraf (Vemurafenib) for Erdheim-Chester Disease with BRAF V600 Mutation

by Editor • November 6, 2017

South San Francisco, CA November 6, 2017 Genentech Press Release — Zelboraf is the first FDA-approved treatment for Erdheim-Chester disease (ECD), a rare blood disease — — Approval based on data from a basket study, which enrolls participants across…